Opendata, web and dolomites

COOPCAT SIGNED

Cooperative Lewis base / Metal-Catalyzed Enantioselective Annulations

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 COOPCAT project word cloud

Explore the words cloud of the COOPCAT project. It provides you a very rough idea of what is the project "COOPCAT" about.

previously    acid    decarboxylative    generate    asymmetric    salt    demonstrated    structures    outwork    greener    c1    stereocontrol    activation    benefits    expansion    lactones    epsilon    base    metal    acting    32    advantages    lewis    acidic    first    healthcare    yield    catalytic    opening    diverse    annulations    single    medicine    demand    ion    small    nucleophilic    isothiourea    energy    compound    chiral    biologically    powerful    classes    identical    enolates    ammonium    acylammonium    rapid    catalysis    43    strategy    innovative    esters    exhibit    plan    synthetic    overcome    alpha    reactivity    offers    gong    selectively    catalysts    class    52    amination    42    ethynyl    tool    employing    substrate    combination    intend    combined    alone    catalyst    dihydrobenzooxazinones    enantiopurity    chemistry    stereoselective    reducing    nucleophiles    dihydropyridazinone    provides    substrates    enantioselective    mode    dihydroquinolinone    time    cycloaddition    impossible    bioactive    molecules    reactions    chemical    regio    cooperative    annulation    compatibility    synthesis    ring    natural   

Project "COOPCAT" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF BRISTOL 

Organization address
address: BEACON HOUSE QUEENS ROAD
city: BRISTOL
postcode: BS8 1QU
website: www.bristol.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 224˙933 €
 EC max contribution 224˙933 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2021-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF BRISTOL UK (BRISTOL) coordinator 224˙933.00

Map

 Project objective

We plan to make innovative use of two catalysts in combination to achieve reactivity impossible with single catalysts acting alone and so develop new synthetic methods for the synthesis of biologically important compound classes. Catalytic approaches to chemical synthesis provide great benefits in terms of reducing the demand for energy and resources, and outwork will enable a ‘greener’ approach to molecules of value in medicine and healthcare. The combination of two catalysts (one acidic, one nucleophilic) offers particular advantages, but presents challenges of compatibility that we intend to overcome. Previously, Gong has demonstrated that chiral isothiourea Lewis base catalyst may be combined with the second mode of activation, such as Lewis acid catalysis, to enable α-amination of esters and decarboxylative [42] annulation of 4-ethynyl dihydrobenzooxazinones. We will build on this work by developing a new class of catalytic asymmetric C1 ammonium enolates as nucleophiles for ring opening and ring expansion chemistry. A chiral Lewis base and a metal salt will work together to promote acylammonium ion formation, ring opening, ring expansion and [43] and [42] cycloaddition chemistry. The reactions will exhibit regio- and stereocontrol, and we will aim for high yield and enantiopurity. This cooperative catalytic strategy, using a chiral Lewis base and a metal salt together, provides a powerful synthetic tool for the rapid stereoselective synthesis of small ring natural products and other bioactive targets. For the first time, it will provide a method for enantioselective [32], [42] and [52] annulations to generate ε-lactones, dihydropyridazinone, and dihydroquinolinone structures. It remains a challenge to selectively generate diverse products from identical substrates, and we intend to demonstrate that this is possible by employing catalyst rather than substrate control.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "COOPCAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "COOPCAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

DGLC (2019)

Domain-general language control: Evidence from the switching paradigm

Read More  

LYSOKIN (2020)

Architecture and regulation of PI3KC2β lipid kinase complex for nutrient signaling at the lysosome

Read More  

GlyCANswer (2019)

Decoding the Cancer Glycoproteome Driven Immune Response

Read More